LIMRA: Workplace Supplemental Health Product Sales Start Strong in 2022
New annualized premium for supplemental health insurance products, (collectively accident, critical illness, cancer, hospital indemnity, and other supplemental health insurance products) increased 6% in the first quarter 2022 year-over-year. During the same period, new annualized premium for workplace life insurance and disability insurance fell, according to LIMRA's workplace benefits sales surveys.
Total workplace supplemental health insurance premium was
Most supplemental health product lines - accident, critical illness, cancer, and hospital indemnity insurance -recorded positive growth in premium in the first quarter of this year. Other supplemental health products, which represent products that do not fit the other categories, such as gap insurance, minimum essential coverage plans, limited benefit medical, and heart/stroke products, saw a decline in sales.
Accident insurance increased 9%, critical illness rose 2%, cancer insurance grew 13%, and hospital indemnity jumped 12%.
"Coming out of the pandemic, employers are looking at the benefits they offer to better support the needs of their workers and we're seeing an increased interest in supplemental health insurance products," said
Life Insurance
For first quarter 2022, the participating life carriers issued
"We saw significant increases during the pandemic, which are hard to sustain. Both the term and permanent product lines experienced year-over-year drops in new annualized premium sales. A few companies, however, drove the overall decline in industry sales, with three of the top five carriers posting significant sales declines," Leary notes.
Group life insurance sales fell 18% while individual life insurance sales were up 28%.
Total workplace disability insurance new premium was
"While the overall industry decline in new premium sales this quarter was driven by a few companies, individual company sales were mixed. More than half of the participating companies reported double- or triple-digit increases in new premium sales," Leary said.
LIMRA's workplace benefits sales surveys for life insurance, disability insurance and supplemental health represent at least 90% of their respective annualized premium markets.
The latest data table with
* * *
Original text here: https://www.limra.com/en/newsroom/news-releases/2022/limra-workplace-supplemental-health-product-sales-start-strong-in-2022/


American Journal of Managed Care Issues Research Articles in July 2022 Edition
Security Benefit appoints Jacquline Morales as chief operating officer
Advisor News
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
More Annuity NewsHealth/Employee Benefits News
- Reports Outline Managed Care Study Results from Harvard University (Inpatient-Only List Removals Shifted Procedures To The Outpatient Setting And Reduced Medicare Spending): Managed Care
- Health and Humor: Picking a Medicare insurance plan is daunting
- Obamacare is getting more expensive in Indiana
- Hays City Commission to consider bids for health insurance, sports complex improvements
- CHOICE arrangements: Not your father’s workplace health insurance
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- U-Haul Holding Company to Participate in Deutsche Bank Conference
- NAIC task force to address LTC riders
- Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
More Life Insurance News